Skip to main content
Premium Trial:

Request an Annual Quote

The Missing Drugs

Before the human genome was sequenced, many researchers thought that such an accomplishment would change how diseases were treated, says Dan Hurley in the New York Times Magazine.

"The ability to sequence DNA quickly and cheaply will also provide the technological basis for a new era in drug development," James Watson, then the director of the National Center for Human Genome Research, wrote in a letter to the Times in 1990, which Hurley quotes.

But rather than speeding up drug development, Hurley says the inclusion of genomics into the drug discovery and development process may have slowed it down. There have been a series of disappointments, he adds: Common diseases don't seem to be caused by a handful of common variants and when a variant is linked to disease, trying to target it can still be difficult. "So far it has produced fewer returns on greater investments," he says.

Hurley notes, though, that there have been successes like Gleevec, but also that many of these drugs found through target-based discovery have only worked for single-gene mutations and only for a small group of people.

"The target-based research made possible by genomics is cool and fascinating," David Swinney, the chief executive of the Institute for Rare and Neglected Diseases Drug Discovery, tells Hurley. "[But] you know what? We almost never use this information before we discover a drug. . . . This whole idea is too simplistic for the overall complexity of biology."

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.